Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
naosaitong wan
- Development stage
- Unknown
- Lead developer
- Shaanxi Momentum Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Naosaitong Wan is a traditional Chinese medicine (TCM) formulated as a pill, primarily used for the treatment of sequelae of cerebral thrombosis and hemorrhage, hemiparalysis, limb numbness, and slurred speech. It is developed and marketed by Shaanxi Momentum Pharmaceutical and other manufacturers in China. The formulation typically consists of multiple herbal and animal-derived ingredients, including Red Ginseng (Hongsen), Radix Achyranthis Bidentatae (Niuxi), Trichosanthes Kirilowii (Tianhuafen), Ground Beetle (Tubiechong), Cortex Moutan (Mudanpi), Rhubarb (Dahuang), Evodia Rutaecarpa (Wuzhuyu), Peach Kernel (Taoren), Earthworm (Dilong), and others. It functions by promoting blood circulation to remove blood stasis, warming and unblocking the meridians, and replenishing qi and nourishing yin.
- Brand names
- LierleMaoxiangRuisaixin
- Other names
- Nao Sai Tong WanNaosaitong脑塞通丸
02
Targets
CASP3 (Caspase-3)CCND1 (Cyclin D1)ICAM1 (Intercellular Adhesion Molecule 1)SRC (Proto-oncogene tyrosine-protein kinase Src)TP53 (Cellular Tumor Antigen p53 R175H)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on naosaitong wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on naosaitong wan.